Treatment of Low Bone Density or Osteoporosis to Prevent Fractures in Men and Women
Publication Date: June 6, 2017
Last Updated: March 14, 2022
Recommendations
ACP recommends that clinicians offer pharmacologic treatment with alendronate, risedronate, zoledronic acid, or denosumab to reduce the risk for hip and vertebral fractures in women who have known osteoporosis. (SH)
565
Title
Treatment of Low Bone Density or Osteoporosis to Prevent Fractures in Men and Women
Authoring Organization
American College of Physicians